EichorEICHOR
Study identifier: NCT07254754 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Recruiting

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

Condition: DIFFUSE LARGE B-CELL LYMPHOMA  ·  Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

PhasePhase 2
Planned participants45
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Single-arm, open-label, multicenter, phase II trial aiming to include approximately 45 patients over 24 months. Patients will receive axicabtagene ciloleucel infusion and will be followed up to 5 years. The total duration of the study is therefore of 7 years.

This description comes directly from the study's public registry record.

Talk to the study team

Auxi Moreno  ·  +34 683636850  ·  amoreno@geltamo.com

Ana María Méndez  ·  administracion@geltamo.com

Always discuss trial participation with your own doctor first.

Locations (15)

Complejo Hospitalario Universitario A CoruñaA Coruña, A Coruña, SpainRecruiting
Hospital Universitario Son EspasesPalma de Mallorca, Balearic Islands, SpainRecruiting
Hospital Universitario Marqués de ValdecillaSantander, Cantabria, SpainRecruiting
Hospital Universitario de SalamancaSalamanca, Castille and León, SpainRecruiting
Hospital Universitari Vall d'HebronBarcelona, Catalonia, SpainRecruiting
Hospital Clinic i Provincial de BarcelonaBarcelona, Catalonia, SpainRecruiting
Institut Català d'oncologia de L'HospitaletL'Hospitalet de Llobregat, Catalonia, SpainRecruiting
Hospital Universitario DonostiaSan Sebastián, Gipuzkoa, SpainRecruiting
Complejo Hospitalario Universitario de Gran Canaria Dr. NegrínLas Palmas de Gran Canaria, Las Palmas, SpainRecruiting
Hospital General Universitario Gregorio MarañónMadrid, Madrid, SpainRecruiting
Hospital Universitario 12 de OctubreMadrid, Madrid, SpainRecruiting
Hospital General Universitario Morales MeseguerMurcia, Murcia, SpainRecruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07254754